Results 1 to 10 of about 2,373 (141)

Intraperitoneal and intracardiac transfusion of recurrent fetal erythroblastosis due to anti-M alloimmunization with unfavorable outcome

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2012
Objective: To present intensive intrauterine treatment of recurrent early onset fetal erythroblastosis due to anti-M alloimmunization. Case Report: A 33-year-old woman, gravid 3, para 1, had anti-M IgG antibody, which caused alloimmunization of her ...
Tzu-Hung Lin   +5 more
doaj   +2 more sources

Hydrops fetalis with septated cystic hygroma

open access: yesApollo Medicine, 2019
Hydrops fetalis is excess accumulation of fluid in the fetus, and fetal cystic hygroma is a manifestation of early lymphatic obstruction. Depending on the severity and cause of hydrops, there may be anasarca of fetus, placentomegaly, ascites, pleural ...
Reddy Ravikanth, Rajalakshmy Prasannan
doaj   +2 more sources

An overview of recent advances in the prevention of erythroblastosis fetalis [PDF]

open access: yesAsian Journal of Transfusion Science
Erythroblastosis fetalis is one of the leading causes of death among newborns and fetuses in India. This condition is characterized by maternal immunoglobin G antibodies destroying the red blood cells (RBCs) of the neonate or fetus, resulting in ...
Aishwarya Balasubramaniam   +2 more
doaj   +2 more sources

Immunotoxicity assessment of rice-derived recombinant human serum albumin using human peripheral blood mononuclear cells. [PDF]

open access: yesPLoS ONE, 2014
Human serum albumin (HSA) is extensively used in clinics to treat a variety of diseases, such as hypoproteinemia, hemorrhagic shock, serious burn injuries, cirrhotic ascites and fetal erythroblastosis.
Kai Fu   +11 more
doaj   +2 more sources

Non-RhD alloimmunization in pregnancy: an updated review [PDF]

open access: yesRevista Brasileira de Ginecologia e Obstetrícia
RhD alloimmunization in pregnancy is still the main cause of hemolytic disease of the fetus and neonate (HDFN). Nevertheless, there are other antigens that may be associated with the occurrence of this phenomenon and that have been growing in proportion,
Sabrina Menes Ares   +3 more
doaj   +2 more sources

Morphologic and Electrophoretic Features of Hemoglobin Bart's Hydrops Fetalis. [PDF]

open access: yesEJHaem
eJHaem, Volume 6, Issue 4, August 2025.
Amid A, Turley E, Au N, Setiadi A.
europepmc   +2 more sources

D-Alloantibody Titration Assessment Study: In Search of a Common Antibody Titration Platform-A BEST Collaborative Study. [PDF]

open access: yesTransfusion
Abstract Background Alloimmunization against D‐antigen can cause severe Hemolytic Disease of the Fetus and Newborn (HDFN). Traditionally, anti‐D‐titers are measured using a saline indirect antiglobulin test (tube testing). Anti‐D‐titers ≥8 during pregnancy trigger an escalation in maternal care. Tube testing is labor‐intensive and known for imprecision.
Aldarweesh FA   +18 more
europepmc   +2 more sources

Placenta Pathologies in Two Patients With Glycogen Storage Disease Type Ia and Preeclampsia. [PDF]

open access: yesJIMD Rep
ABSTRACT Little is known about pregnancies and placental changes in women with glycogen storage disease type Ia (GSD Ia). We report on two primipara with GSD Ia who both developed preeclampsia and whose newborns were small for gestational age. Both placentas showed sonomorphological and macroscopical abnormalities.
Laufs V   +7 more
europepmc   +2 more sources

The Allelic and Phenotypic Frequencies of the ABO and Rh Blood Types in Pregnant Women in Addis Ababa, Ethiopia. [PDF]

open access: yesBiomed Res Int
Background: ABO–rhesus (Rh) blood testing screens blood types according to the antigenic properties of red blood cells. Objective: This study reports the allelic and phenotypic frequency distribution of the ABO and Rh blood groups in pregnant women who attended antenatal care (ANC) at Zewditu Memorial Hospital in Addis Ababa, Ethiopia, and the ...
Tedbabe MW, Birri DJ, Desta TT.
europepmc   +2 more sources

Prevalence of erythrocyte alloimmunization in polytransfused patients [PDF]

open access: yesEinstein (São Paulo), 2011
Objective: To determine the incidence and the rate of red blood cellalloimmunization in polytransfused patients. Methods: A polytransfusedpatient was defined as having received at least 6 units of red cellconcentrates during a 3-month period. The records
Roberto de Oliveira Cruz   +6 more
doaj   +4 more sources

Home - About - Disclaimer - Privacy